Evidence map›Paper›PMID 41163367›Full record

Trial reportGut microbes2025

Gut enterotype- and body mass index (BMI)-dependent effects of anthocyanin supplementation on gut microbiota composition in individuals at risk for cognitive decline: a randomized placebo-controlled trial.

Yohannes Seyoum, Chiara de Lucia, Khadija Khalifa, Anne Katrine Bergland, Dag Aarsland, Mark van der Giezen

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Gut microbes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yohannes SeyoumDepartment of Chemistry, Bioscience, and Environmental Engineering, University of Stavanger (UiS), Stavanger, Norway.
Chiara de LuciaCentre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway.
Khadija KhalifaCentre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway.
Anne Katrine BerglandCentre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway.
Dag AarslandCentre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway.
Mark van der GiezenDepartment of Chemistry, Bioscience, and Environmental Engineering, University of Stavanger (UiS), Stavanger, Norway.ORCID 0000-0002-1033-1335

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anthocyanins, bioactive flavonoids found in berries, modulate gut microbiota composition and influence health outcomes. This study investigated the effects of anthocyanin supplementation on gut microbiota and cognition in older adults (60-80 y) at risk of cognitive decline due to mild cognitive impairment (MCI) or cardiometabolic disorders (CMD). In a 24-week, randomised, double-blind, placebo-controlled trial (

Indexed as

AnthocyaninsBacteriaCognitive DysfunctionGastrointestinal MicrobiomeAgedAged, 80 and overBody Mass IndexCognitionDietary SupplementsDouble-Blind MethodFemaleHumansMaleMiddle AgedRNA, Ribosomal, 16SAnthocyaninsRNA, Ribosomal, 16SAnthocyaninsbody mass indexenterotypemicrobiotamild cognitive impairmentpersonalized nutrition

Identifiers

PMID41163367
PMCPMC12578313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.